Symptom guide · Pregnancy Smart
Echogenic intracardiac focus
By trimester
Weeks 1–13
1st trimester
An echogenic intracardiac focus is generally discussed after a second-trimester anatomy scan, not as a first-trimester finding. First-trimester decisions instead center on whether aneuploidy screening was completed and what those results showed. Keep the planned anatomy scan even after a low-risk screening result.
Weeks 14–27
2nd trimester
At the anatomy scan, confirm whether the echogenic intracardiac focus is truly isolated after a detailed survey. If prior serum or cell-free DNA screening was negative, current guidance recommends no additional assessment for the focus. Without prior screening, discuss cell-free DNA or quad screening rather than interpreting the spot alone.
Weeks 28–birth
3rd trimester
An isolated echogenic intracardiac focus with negative screening does not need a third-trimester scan, fetal echocardiogram, or newborn assessment solely because of the focus. Follow-up changes if another anomaly, growth concern, or additional soft marker is present, because the finding is then no longer isolated.
What does the evidence show for echogenic intracardiac focus?
- SMFM defines an isolated soft marker as one found without a structural anomaly, growth restriction, or another marker after a detailed ultrasound. With negative serum or cell-free DNA screening, an isolated echogenic intracardiac focus is a normal variant with no indication for fetal echocardiography, follow-up ultrasound, or postnatal assessment solely for that finding. 1
- In a retrospective cohort of 391 pregnancies with an isolated echogenic intracardiac focus, none of the 348 pregnancies with low-risk triple-screen results had trisomy 21, while one case occurred among 43 with a high-risk screen. This older serum-screening cohort supports interpreting the focus together with prior screening, not alone. 2
- A blinded review of 200 routine 18-to-22-week scans found true echogenic intracardiac foci in 5.5% but false bright reflections in 17%. This small imaging study shows that angle-dependent artifacts can mimic a focus and that image review matters when the finding is uncertain. 3
- A prospective comparison of 138 fetuses with an echogenic intracardiac focus and 167 without one found nearly identical frequencies of structural cardiac abnormalities on detailed fetal echocardiography, with no statistically significant difference. The study was too small to establish equivalence but did not support EIF as a structural heart defect. 4
- A systematic review of 19 cohort studies found most echogenic intracardiac foci were left-sided and found no evidence that EIF alone was highly predictive of chromosomal abnormality or preterm birth. A possible association between persistent right-sided foci and cardiac abnormality was based on rare cases and limited-quality evidence. 5
When should I call my provider about echogenic intracardiac focus?
An isolated echogenic intracardiac focus does not cause maternal symptoms and is not itself an emergency. Promptly contact the obstetric team if the report also lists a structural anomaly, growth restriction, another soft marker, or an incomplete anatomy survey, because the isolated-finding guidance may not apply. Seek urgent obstetric care for pregnancy warning signs such as heavy bleeding, fluid leakage, severe pain, or reduced fetal movement. When in doubt, call your obstetric team the same day. Early input almost always beats waiting, and the on-call line exists exactly for this.
Frequently asked questions
Is an echogenic intracardiac focus a heart defect?
No. An echogenic intracardiac focus is a bright ultrasound spot, usually in a ventricle, rather than a structural hole or malformed heart part. A prospective comparison found no significant increase in structural cardiac abnormalities among fetuses with the finding.
What does isolated echogenic intracardiac focus mean?
Isolated means a detailed ultrasound found no structural anomaly, fetal growth restriction, or additional soft marker. That definition matters because guidance for a lone focus after negative screening does not apply when another finding is present.
Does an echogenic intracardiac focus mean Down syndrome?
No. EIF is a soft marker, not a chromosome result. With negative serum or cell-free DNA screening and no other ultrasound finding, specialist guidance recommends no additional aneuploidy assessment for the focus alone.
What if no aneuploidy screening was done before an EIF was found?
Current guidance recommends counseling about the estimated probability of trisomy 21 and offering noninvasive screening with cell-free DNA or a quad screen if cell-free DNA is unavailable or unaffordable. The ultrasound spot itself is not a definitive test.
Does an isolated EIF require a fetal echocardiogram?
Not when the anatomy survey is otherwise normal and prior serum or cell-free DNA screening is negative. SMFM specifically states that an isolated EIF in that setting does not indicate fetal echocardiography. A separate structural concern would change that decision.
Does EIF need a repeat ultrasound?
No repeat scan is recommended solely for an isolated EIF after negative screening. A clinician may schedule later imaging for another reason, such as growth or a separate anatomy finding, but that is different from following the focus itself.
Does it matter whether the EIF is in the left or right ventricle?
Most foci in the systematic review were left-sided. Rare persistent right-sided findings had a possible association with cardiac abnormalities, but the evidence was limited. Location should be interpreted with the full anatomy scan rather than used alone to predict an outcome.
Can ultrasound reflections be mistaken for an EIF?
Yes. One blinded imaging study found angle-dependent bright reflections more often than true foci. If the report is uncertain, image review or completion of the anatomy survey can clarify whether a persistent focus is actually present.
Related in the library
References
PubMed · https://pubmed.ncbi.nlm.nih.gov/16318619/
Echogenic intracardiac focus: potential for misdiagnosis
PubMed · https://pubmed.ncbi.nlm.nih.gov/14620892/
Intracardiac echogenic focus: no apparent association with structural cardiac abnormality
PubMed · https://pubmed.ncbi.nlm.nih.gov/10867482/
PubMed · https://pubmed.ncbi.nlm.nih.gov/38648215/
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
